Koninklijke Philips N.V.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Roy W. O. Jakobs
- Full Time Employees
- 67,247
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Philips Center Amsterdam Netherlands 1096 BC
- IPO Date
- Mar 17, 1980
- CIK
- 0000313216
- Website
- philips.com
- Similar Companies
- Business
- Koninklijke Philips N.V. is a global health technology company headquartered in Amsterdam, Netherlands, founded in 1891. It operates mainly across the diagnosis and treatment, connected care, and personal health segments, offering a broad range of products and services including precision diagnostic imaging systems, image-guided therapy solutions, patient monitoring devices, health informatics, respiratory care, and personal health and home care products. Its core portfolio features advanced diagnostic imaging devices such as CT and ultrasound systems, AI-enabled clinical decision support tools, enterprise health informatics platforms, sleep and respiratory care solutions, and consumer health categories including grooming and oral healthcare devices. Philips serves markets primarily in North America, Western Europe, Greater China, and other growth geographies. Recent developments include the launch of the AI-powered Philips CT 5300 system, integrating advanced hardware and software with artificial intelligence to enhance imaging quality and boost clinical workflow efficiency. This system offers ultra-low dose screening capabilities and improved diagnostic confidence with smart workflow automation. Philips has also introduced two FDA-cleared AI applications for its Lumify point-of-care ultrasound system, enabling smarter, faster frontline care in anesthesia, emergency medicine, and critical care. Strategically, Philips has maintained cost discipline, restructuring its supply chain and reducing overhead while investing selectively in innovation projects. The company reported a reduced M&A spend in 2023 compared to 2022, focusing on operational improvements and cash preservation. Philips’ business model is arranged into global, end-to-end business units—Diagnosis & Treatment, Connected Care, and Personal Health—each managing their operations independently. Notably, the company is investing in improving productivity and operational efficiency with multi-year savings programs and enhanced product pipeline focus. Its recent partnerships include collaborations with healthcare institutions such as Hôpital Fondation Rothschild in Paris and Erasmus University Medical Center. Philips aims to improve 2.5 billion lives annually by 2030, reflecting its strategic commitment to health technology innovation and broad accessibility. Financially, Philips generated approximately $19.5 billion in revenue in 2024, employing around 67,800 people globally. The company continues to navigate challenges such as supply chain disruptions and market demand fluctuations, particularly in China, while driving growth in mature markets and leveraging AI and digital technologies to reinforce its competitive position in healthcare technology. Its leadership in diagnostic imaging, patient monitoring, connected care, and personal health makes it a key player in the global health technology industry.
AI is boosting accuracy for clinicians, Philips North America CEO says
NYSE Content Update: HUD Sec. Turner Highlights National Homeownership Month
AI Moves from Promise to Practice, Transforming Clinical Care Across the U.S., Philips Report Finds
Philips Future Health Index 2026: AI is already saving clinicians time and delivering measurable impact in healthcare
WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland
WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland
Here's Why Royal Philips (PHG) is a Strong Value Stock
Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound
Philips announces exchange ratio for 2025 dividend
Philips announces exchange ratio for 2025 dividend
Here's Why Royal Philips (PHG) is a Strong Momentum Stock
Disney and Philips bring together beloved storytelling and innovative technology to support kids undergoing MRI exams
Philips Smart Locks Launch at Jarir Bookstore
Koninklijke Philips: AI Upside, And Margin Expansion Create An Attractive Entry Point
Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026
Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026
Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures
Philips to deliver vital technology for hospital-at-home care for up to 15,000 patients annually in Region Stockholm
Philips to deliver vital technology for hospital-at-home care for up to 15,000 patients annually in Region Stockholm
Why Royal Philips (PHG) is a Top Value Stock for the Long-Term